By Charlie Tetiyevsky,

There are few treatments available for people with severe diabetic nerve pain.

Roughly 60 to 70 percent of diabetic patients—that’s more than 17 million Americans—suffer from nerve damage. This can result in chronic pain across the body, even leading to agonizing sensitivity to the slightest touch. Even though the opioid prescribed for diabetic neuropathy, tapentadol, is 65 percent less addictive than extended-release oxycodone, it still has the potential for abuse. And there are few effective alternatives. That’s why California-based cannabinoid pharmaceutical company Cannabis Science developed the CBIS Transdermal Patch, a cannabis-based patch for chronic pain. According to the company, they’ve already been contacted by hundreds of patients interested in it. The response, their press release said, has been “overwhelming.”

The high-cannabinoid patch is designed to target nerve pain

Try This Transdermal Article 04 600x400 This cannabis based patch could help solve the chronic pain epidemic
Photo courtesy of Green Flower

Cannabis Science’s patches are extended release, like other nerve pain medicines, letting out concentrated levels of cannabidiol (CBD) into the central nervous system via the bloodstream. Dr. Allen Herman, Chief Medical Officer of Cannabis Science and former NIH scientist, explains that the patch uses “body heat [to melt] thin layers of high-potency cannabinoid formulations embedded in the adhesive.” They then, Herman says, work to reduce inflammation, which can lessen nerve pain.

According to the company, the topical nature of the patch means that it can target the specific spot where patients are experiencing chronic pain. Developers of the drug assert that the patch can help with nerve damage from causes ranging from vitamin deficiency to leprosy.

Once on the market, the highly-anticipated patches will only be sold in dispensaries. The first place to stock the product will be Kush Factory in Los Angeles’ Koreatown neighborhood.

Source: HERB

Related image

Adding old study related to this.

First Cannabinoid-Based Transdermal Patch for Chronic Pain Is Ready for Release – Treats Fibromyalgia and Diabetic Nerve Pain

A company focused on the healing power of cannabis came out with an effective patch that relieves fibromyalgia symptoms and diabetic nerve pain.

With this knowledge on hand, cannabis deserves a better reputation that the one it already has.

The cannabis patches are nothing but transdermal patches that release the “good stuff” in the skin, which later travel through the bloodstream.

These patches relieve neurological nerve pain caused by diabetes and fibromyalgia. Experts from the company explain that controlled doses can’t harm the body nor cause any side effects.

Cannabis Science assure their clients that their patches can heal every affected part in the body. Transdermal methods work better than any other solution, including topical, oral, intramuscular or intravenous applications.

These patches guarantee that the needed amount of the healing content is delivered into the patient.

It can be applied through a penetrable membrane that allows full absorption or thin layers that melt on the skin. The thin layers are packed with powerful cannabinoid extract that reaches for the central nervous system, and relieves pain.

CBD is the second most important cannabinoid in cannabis. As you already know, THC is the first cannabinoid. CBD offers huge anti-inflammatory and pain-relieving potential. There’re almost no side effects, except for the hallucinogenic effect.

Mr. Raymond C. Dabney, CEO of Cannabis Science says that their product is just a tiny bit of the whole capacity of Cannabis Science.

“The development of these two new pharmaceutical medicinal applications are just the tip of the iceberg for what we see as the future for Cannabis Science.

While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications,” explained the CEO.

Over 10% of all Americans are affected by fibromyalgia, and many don’t even know they have it.

Neuropathic nerve pain is common in many people worldwide, and these patches can help in the treatment of both diseases. There’s a strong possibility that the patches even cure these health problems.

“As more states nationwide legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years,” finished Dabney.



Please enter your comment!
Please enter your name here